Promethazine Downregulates Wnt/β-Catenin Signaling and Increases the Biomechanical Forces of the Injured Achilles Tendon in the Early Stage of Healing.


Journal

The American journal of sports medicine
ISSN: 1552-3365
Titre abrégé: Am J Sports Med
Pays: United States
ID NLM: 7609541

Informations de publication

Date de publication:
04 2022
Historique:
pubmed: 3 3 2022
medline: 19 4 2022
entrez: 2 3 2022
Statut: ppublish

Résumé

Wnt/β-catenin signaling suppresses the differentiation of cultured tenocytes, but its roles in tendon repair remain mostly elusive. No chemical compounds are currently available to treat tendon injury. We hypothesized that the inhibition of Wnt/β-catenin signaling would accelerate tendon healing. Controlled laboratory study. Tendon-derived cells (TDCs) were isolated from rat Achilles tendons. The right Achilles tendon was injured via a dermal punch, while the left tendon was sham operated. A Wnt/β-catenin inhibitor, IWR-1, and an antihistamine agent, promethazine (PH), were locally and intramuscularly injected, respectively, for 2 weeks after surgery. The healing tendons were histologically and biomechanically evaluated. The amount of β-catenin protein was increased in the injured tendons from postoperative weeks 0.5 to 2. Inhibition of Wnt/β-catenin signaling by IWR-1 in healing tendons improved the histological abnormalities and decreased β-catenin, but it compromised the biomechanical properties. As we previously reported that antihistamine agents suppressed Wnt/β-catenin signaling in human chondrosarcoma cells, we examined the effects of antihistamines on TDCs. We found that a first-generation antihistamine agent, PH, increased the expression of the tendon marker genes IWR-1 and PH suppressed Wnt/β-catenin signaling and improved the histological abnormalities of healing tendons. IWR-1, however, compromised the biomechanical properties of healing tendons, whereas PH improved them. PH is a candidate repositioned drug that potentially accelerates tendon repair.

Sections du résumé

BACKGROUND
Wnt/β-catenin signaling suppresses the differentiation of cultured tenocytes, but its roles in tendon repair remain mostly elusive. No chemical compounds are currently available to treat tendon injury.
HYPOTHESIS
We hypothesized that the inhibition of Wnt/β-catenin signaling would accelerate tendon healing.
STUDY DESIGN
Controlled laboratory study.
METHODS
Tendon-derived cells (TDCs) were isolated from rat Achilles tendons. The right Achilles tendon was injured via a dermal punch, while the left tendon was sham operated. A Wnt/β-catenin inhibitor, IWR-1, and an antihistamine agent, promethazine (PH), were locally and intramuscularly injected, respectively, for 2 weeks after surgery. The healing tendons were histologically and biomechanically evaluated.
RESULTS
The amount of β-catenin protein was increased in the injured tendons from postoperative weeks 0.5 to 2. Inhibition of Wnt/β-catenin signaling by IWR-1 in healing tendons improved the histological abnormalities and decreased β-catenin, but it compromised the biomechanical properties. As we previously reported that antihistamine agents suppressed Wnt/β-catenin signaling in human chondrosarcoma cells, we examined the effects of antihistamines on TDCs. We found that a first-generation antihistamine agent, PH, increased the expression of the tendon marker genes
CONCLUSION
IWR-1 and PH suppressed Wnt/β-catenin signaling and improved the histological abnormalities of healing tendons. IWR-1, however, compromised the biomechanical properties of healing tendons, whereas PH improved them.
CLINICAL RELEVANCE
PH is a candidate repositioned drug that potentially accelerates tendon repair.

Identifiants

pubmed: 35234523
doi: 10.1177/03635465221077116
doi:

Substances chimiques

beta Catenin 0
Promethazine FF28EJQ494

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1317-1327

Auteurs

Takefumi Sakaguchi (T)

Division of Neurogenetics, Center for Neurological Diseases and Cancer, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
Department of Orthopaedic Surgery, Graduate School of Medicine, Nagoya University, Nagoya, Japan.

Bisei Ohkawara (B)

Division of Neurogenetics, Center for Neurological Diseases and Cancer, Graduate School of Medicine, Nagoya University, Nagoya, Japan.

Yasuzumi Kishimoto (Y)

Division of Neurogenetics, Center for Neurological Diseases and Cancer, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
Department of Orthopaedic Surgery, Graduate School of Medicine, Nagoya University, Nagoya, Japan.

Kentaro Miyamoto (K)

Division of Neurogenetics, Center for Neurological Diseases and Cancer, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
Department of Orthopaedic Surgery, Graduate School of Medicine, Nagoya University, Nagoya, Japan.

Shinya Ishizuka (S)

Department of Orthopaedic Surgery, Graduate School of Medicine, Nagoya University, Nagoya, Japan.

Hideki Hiraiwa (H)

Department of Orthopaedic Surgery, Graduate School of Medicine, Nagoya University, Nagoya, Japan.

Naoki Ishiguro (N)

Department of Orthopaedic Surgery, Graduate School of Medicine, Nagoya University, Nagoya, Japan.

Shiro Imagama (S)

Department of Orthopaedic Surgery, Graduate School of Medicine, Nagoya University, Nagoya, Japan.

Kinji Ohno (K)

Division of Neurogenetics, Center for Neurological Diseases and Cancer, Graduate School of Medicine, Nagoya University, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH